|
|
| | RX-3117 Basic information |
| Product Name: | RX-3117 | | Synonyms: | RX-3117;4-Amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl]-2(1H)-pyrimidinone;RX-3117; RX3117; RX 3117; TV-1360; TV1360; TV 1360; FLUOROCYCLOPENTENYLCYTOSINE;TV 1360;TV1360;TV-1360;CS-1677;2(1H)-Pyrimidinone, 4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl]- | | CAS: | 865838-26-2 | | MF: | C10H12FN3O4 | | MW: | 257.22 | | EINECS: | | | Product Categories: | | | Mol File: | 865838-26-2.mol |  |
| | RX-3117 Chemical Properties |
| Boiling point | 516.3±60.0 °C(Predicted) | | density | 1.82±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:50.0(Max Conc. mg/mL);194.39(Max Conc. mM) | | pka | 12.88±0.70(Predicted) | | form | Powder |
| | RX-3117 Usage And Synthesis |
| Definition | ChEBI: Roducitabine is a triol that is (1S,2R)-4-fluoro-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol which is substituted by a 4-amino-2-oxopyrimidin-1(2H)-yl group at position 5. It is a cytidine analog which exhibits anticancer activity in several cancers, including gemcitabine-resistant tumours. It has a role as an antimetabolite, an antineoplastic agent, a prodrug, a DNA synthesis inhibitor and an apoptosis inducer. It is an organofluorine compound, a primary allylic alcohol and a triol. |
| | RX-3117 Preparation Products And Raw materials |
|